Skip to content
DataLookout
Menu

MIND-CKDNCT04099992

Mindfulness in Chronic Kidney Disease

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 9 versions: 7 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 7 words Show 6 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Sep 2026 to May 7, 2026
    • Enrollment target: estimated 150 to confirmed 151
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Notable Primary and study completion dates: Aug 2025 to Sep 2026v8
  3. Notable Eligibility criteria revised
    • Secondary endpoints: 4 to 5
    • Primary endpoint revised
    • Study description expanded, about 378 words
    v7
  4. Notable Primary and study completion dates: Aug 2024 to Aug 2025
    • Enrollment target: 125 to 150
    • Collaborators expanded, about 8 words
    v5
  5. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    • Study title expanded, about 2 words
    v3
  6. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in Mean Muscle Sympathetic Nerve Activity (MSNA) Burst Frequency (BF)
Timeframe: Baseline, 8 weeks

Secondary (5)

Change in Daytime Blood Pressure (BP)
Change in Nocturnal Dipping of Blood Pressure (BP)
Change in Heart Rate Assessed by 24-hour EKG Monitoring
Change in Baroreflex Sensitivity (BRS) Among Protocol 2 Participants
Change in Tumor Necrosis Factor (TNF) Level Among Protocol 2 Participants

Arms and interventions

Mindfulness-Based Stress Reduction (MBSR)Experimental

Mindfulness-Based Stress Reduction (MBSR) tis designed to provide education about mindfulness and stress; experiential mindfulness practice, and discussion of participants' experiences with mindfulness practice. MBSR is delivered in 8 weekly 2.5-hour group sessions and one day-long retreat that occurs after the 6th session.

Health enhancement program (HEP)Active comparator

Health enhancement program (HEP) is designed to provide a structurally parallel, active control intervention to MBSR with health benefits in their own right, while omitting any components of mindfulness. HEP participants will meet with a health educator in a group setting for 8 weekly 2.5-hour sessions with a day-long retreat.

MBSR+tVNSExperimental

Mindfulness-Based Stress Reduction (MBSR) tis designed to provide education about mindfulness and stress; experiential mindfulness practice, and discussion of participants' experiences with mindfulness practice. MBSR is delivered in 8 weekly 2.5-hour group sessions and one day-long retreat that occurs after the 6th session. Transcutaneous vagus nerve stimulation (tVNS) is a simple, noninvasive, self-administered adjunctive therapy, that may enhance the sympatho-inhibitory effects of mindfulness meditation (MM) in chronic kidney disease (CKD) .

MBSR+sham-tVNSActive comparator

Mindfulness-Based Stress Reduction (MBSR) tis designed to provide education about mindfulness and stress; experiential mindfulness practice, and discussion of participants' experiences with mindfulness practice. MBSR is delivered in 8 weekly 2.5-hour group sessions and one day-long retreat that occurs after the 6th session. Sham stimulation will be delivered using a sham device that is identical in appearance and function to tVNS, but programmed to produce a lower frequency biphasic signal that can be felt by the participant without actually stimulating the vagus nerve.

HEP+tVNSExperimental

Health enhancement program (HEP) is designed to provide a structurally parallel, active control intervention to MBSR with health benefits in their own right, while omitting any components of mindfulness. HEP participants will meet with a health educator (a registered dietician) in a group setting for 8 weekly 2.5-hour sessions. Transcutaneous vagus nerve stimulation (tVNS) is a simple, noninvasive, self-administered adjunctive therapy, that may enhance the sympatho-inhibitory effects of mindfulness meditation (MM) in chronic kidney disease (CKD).

HEP+sham-tVNSActive comparator

Health enhancement program (HEP) is designed to provide a structurally parallel, active control intervention to MBSR with health benefits in their own right, while omitting any components of mindfulness. HEP participants will meet with a health educator in a group setting for 8 weekly 2.5-hour sessions. Sham stimulation is be delivered using a sham device that is identical in appearance and function to tVNS, but programmed to produce a lower frequency (0.1 Hz) biphasic signal that can be felt by the participant without actually stimulating the vagus nerve.

Behavioral: Mindfulness-based stress reduction (MBSR), Health enhancement program (HEP)

Devices: Transcutaneous Vagus Nerve Stimulation (tVNS), Sham-transcutaneous Vagus Nerve Stimulation (tVNS)

Sites

1 site in 1 country

  • Atlanta VA Medical CenterAtlanta, Georgia, United States